XML 22 R9.htm IDEA: XBRL DOCUMENT v2.3.0.15
Segment Reporting
9 Months Ended
Sep. 30, 2011
Segment Reporting [Abstract] 
SEGMENT REPORTING
(3) SEGMENT REPORTING
We operate in one segment, specialty pharmaceutical products. Management has chosen to organize the Company based on the type of products sold. All of our assets are located in the United States. We had sales to non-U.S. customers of $0 and $0.1 million during the three months ended September 30, 2011 and 2010, respectively. We had sales of $0.1 million to non-U.S. customers during each of the nine months ended September 30, 2011 and 2010.
The Company’s net revenues consisted of the following for the three and nine months ended September 30, 2011 and 2010:
                                 
    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2011     2010     2011     2010  
Products:
                               
Acetadote
  $ 10,882,342     $ 9,600,427     $ 31,594,237     $ 25,632,260  
Kristalose
    2,077,310       2,506,894       6,249,662       7,088,294  
Caldolor
    47,966       14,103       145,947       79,184  
Other
    46,660       69,446       121,100       261,719  
 
                       
Total net revenues
  $ 13,054,278     $ 12,190,870     $ 38,110,946     $ 33,061,457